T1	Participants 50 131	patients receiving goal-directed fluid therapy undergoing major abdominal surgery
T2	Participants 389 432	patients undergoing major abdominal surgery
T3	Participants 703 746	patients undergoing major abdominal surgery
T4	Participants 994 1188	Patients undergoing elective major colorectal or urological surgery who had an AT of <11 mL 路 kg(-1) 路 min(-1) or an AT of 11 to 14 mL 路 kg(-1) 路 min(-1) with a history of ischemic heart disease
